The synthetic chemoattractant Trp-Lys-Tyr-Met-Val-DMet activates neutrophils preferentially through the lipoxin A4 receptor

Blood

Volumn 95, Issue 5, 2000, Pages 1810-1818

  Dahlgren, Claes ^a   Christophe, Thierry ^b   Boulay, Francois ^b   Madianos, Phoebus N ^b   Rabiet, Marie J ^b   Karlsson, Anna ^b  

^a Dept Med Microbiol and Immunol   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHEMOATTRACTANT; COMPLEMENT COMPONENT C3; CYCLOSPORIN H; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LIPOXIN A; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MOLECULAR DYNAMICS; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; RECEPTOR BINDING;

EID: 0034161336     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.5.1810.005k06_1810_1818     Document Type: Article

References (77)

1. Featherstone C, ed. Phagocytosis: Trends Cell Biology, vol. 5. 1995:85-142.
2. Ali H, Haribabu B, Richardson RM, Snyderman R. Mechanisms of inflammation and leukocyte activation. Med Clin North Am. 1997;81:1-28.
3. Ye RD, Boulay F. Structure and function of leukocyte chemoattractant receptors. Adv Pharmacol. 1997;39:221-289.
4. Amatruda TT 3rd, Dragas Graonic S, Holmes R, Perez HD. Signal transduction by the formyl peptide receptor. Studies using chimeric receptors and site-directed mutagenesis define a novel domain for interaction with G-proteins. J Biol Chem. 1995;270:28,010-28,013.
5. Dusi S, Donini M, Rossi F. Mechanisms of NADPH oxidase activation in human neutrophils: p67phox is required for the translocation of rac 1 but not of rac 2 from cytosol to the membranes. Biochem J. 1995;308:991-994.
6. Rainger GE, Buckley C, Simmons DL, Nash GB. Cross-talk between cell adhesion molecules regulates the migration velocity of neutrophils. Curr Biol. 1997;7:316-325.
7. Kefalas P, Allport JR, Donnelly LE, et al. Arginine-specific mono(ADP-ribosyl)transferase activity in human neutrophil polymorphs. A possible link with the assembly of filamentous actin and chemotaxis. Adv Exp Med Biol. 1997;419:241-244.
8. Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89:3503-3521.
9. Jesaitis AJ. Structure of human phagocyte cytochrome b and its relationship to microbicidal superoxide production. J Immunol. 1995;155:3286-3288.
10. Wientjes FB, Segal AW. NADPH oxidase and the respiratory burst. Semin Cell Biol. 1995;6:357-365.
11. Bokoch GM. Regulation of the phagocyte respiratory burst by small GTP-binding proteins. Trends Cell Biol. 1995;5:109-113.
12. Sue-A-Quan AK, Fialkow L, Vlahos CJ, et al. Inhibition of neutrophil oxidative burst and granule secretion by wortmannin: potential role of MAP kinase and renaturable kinases. J Cell Physiol. 1997;172:94-108.
13. Dahlgren C. Difference in extracellular radical release after chemotactic factor and calcium ionophore activation of the oxygen radical-generating system in human neutrophils. Biochim Biophys Acta. 1987;930:33-38.
14. Johansson A, Jesaitis AJ, Lundqvist H, et al. Different subcellular localization of cytochrome b and the dormant NADPH-oxidase in neutrophils and macrophages: effect on the production of reactive oxygen species during phagocytosis. Cell Immunol. 1995;161:61-71.
15. Karlsson A, Markfjäll M, Strömberg N, Dahlgren C. Escherichia coli-induced activation of neutrophil NADPH-oxidase: lipopolysaccharide and formylated peptides act synergistically to induce release of reactive oxygen metabolites. Infect Immun. 1995;63:4606-4612.
16. Baek SH, Seo JK, Chae CB, Suh PG, Ryu SH. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J Biol Chem. 1996;271:8170-8175.
17. Seo JK, Choi SY, Kim Y, et al. A peptide with unique receptor specificity: stimulation of phosphoinositide hydrolysis and induction of superoxide generation in human neutrophils. J Immunol. 1997;158:1895-1901.
18. Fiore S, Maddox JF, Perez HD, Serhan CN. Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J Exp Med. 1994;180:253-260.
19. Follin P, Briheim G, Dahlgren C. Mechanisms in neutrophil priming: characterization of the oxidative response induced by formylmethionyl-leucylphenylalanine in human exudated cells. Scand J Immunol. 1991;34:317-322.
20. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77-89.
21. Andersson T, Dahlgren C, Lew PD, Stendahl O. Cell surface expression of fMet-Leu-Phe receptors on human neutrophils. Correlation to changes in the cytosolic free Ca2+ level and action of phorbol myristate acetate. J Clin Invest. 1987;79:1226-1233.
22. Gallin JI, Clark RA, Kimball HR. Granulocyte chemotaxis: an improved in vitro assay employing 51 Cr-labeled granulocytes. J Immunol. 1973;110:233-240.
23. Briheim G, Coble B, Stendahl O, Dahlgren C. Exudate polymorphonuclear leukocytes isolated from skin chambers are primed for enhanced response to subsequent stimulation with chemoattractant f-Met-Leu-Phe and C3-opsonized yeast particles. Inflammation. 1968;12:1411-152.
24. Agace WW, Patarroyo M, Svensson M, Carlemalm E, Svanborg C. Escherichia coli induces transuroepithelial neutrophil migration by an intercellular adhesion molecule-1-dependent mechanism. Infect Immun. 1995;63:4054-4062.
25. Madianos PN, Papapanou PN, Sandras J. Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration. Infect Immun. 1997;65:3983-3990.
26. Stendahl O, Molin L, Dahlgren C. The inhibition of polymorphonuclear leukocyte cytotoxicity by dapsone. A possible mechanism in the treatment of dermatitis herpetiformis. J Clin Invest. 1978;62:214-220.
27. Lundqvist H, Dahlgren C. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Radic Biol Med. 1996;20:785-792.
28. Lundahl J, Dahlgren C, Eklund A, Hed J, Hernbrand R, Tornling G. Quartz selectively downregulates CR1 on activated human granulocytes. J Leukoc Biol. 1993;53:99-103.
29. Borregaard N, Heiple JM, Simons ER, Clark RA. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol. 1983;97:52-61.
30. Kjeldsen L, Bjerrum OW, Hovgaard D, Johnsen AH, Sehested M, Borregaard N. Human neutrophil gelatinase: a marker for circulating blood neutrophils. Purification and quantitation by enzyme linked immunosorbent assay. Eur J Haematol. 1992;49:180-191.
31. Metcalf JA, Gallin JI, Nauseef WM, Root RK. Laboratory Manual of Neutrophil Function. New York: Raven Press; 1986.
32. Lundqvist H, Karlsson A, Follin P, Sjölin C, Dahlgren C. Phagocytosis following translocation of the neutrophil b-cytochrome from the specific granule to the plasma membrane is associated with an increased leakage of reactive oxygen species. Scand J Immunol. 1992;36:885-B91.
33. Zhen L, King AA, Xiao Y, Chanock SJ, Orkin SH, Dinauer MC. Gene targeting of X chromosome-linked chronic granulomatous disease locus in a human myeloid leukemia cell line and rescue by expression of recombinant gp91 phox. Proc Natl Acad Sci USA. 1993;90:9832-9836.
34. Tonetti DA, Henning Chubb C, Yamanishi DT, Huberman E. Protein kinase C-beta is required for macrophage differentiation of human HL-60 leukemia cells. J Biol Chem. 1994;269:23,230-23,235.
35. Wenzel-Seifert K, Seifert R. Cyclosporin H is a potent and selective formyl peptide receptor antagonist. Comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L- phenylalanine and cyclosporins A, B, C, D, and E. J Immunol. 1993;150:4591-4599.
36. Wenzel-Seifert K, Hurt CM, Seifert R. High constitutive activity of the human formyl peptide receptor. J Biol Chem. 1998;273:24,181-24,189.
37. Tardif M, Mery L, Brouchon L, Boulay F. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells. J Immunol. 1993;150:3534-3545.
38. Jesaitis AJ, Klotz KN. Cytoskeletal regulation of chemotactic receptors: molecular complexation of N-formyl peptide receptors with G proteins and actin. Eur J Haematol. 1993;51:288-293.
39. Lundqvist H, Gustafsson M, Johansson A, Särndahl E, Dahlgren C. Neutrophil control of formylmethionyl-leucyl-phenylalanine induced mobilization of secretory vesicles and NADPH-oxidase activation: effect of an association of the ligand-receptor complex Io the cytoskeleton. Biochim Biophys Acta. 1994;1224:43-50.
40. Liu L, Harbecke O, Elwing H, Follin P, Karlsson A, Dahlgren C. The desensitization of formyl peptide receptors is abolished in calcium ionophore primed neutrophils. J Immunol. 1998;160:2463-2468.
41. Kuijpers TW, Tool AT, van der School CE, et al. Membrane surface antigen expression on neutrophils: a reappraisal ol the use of surface markers for neutrophil activation. Blood. 1991;78:1105-1111.
42. Dahlgren C. Temporal adaptation of human neutrophil metabolic responsiveness to the peptide formylmethionyl-leucyl-phenylalanine: a comparison between human neutrophils and granule-depleted neutrophil cytoplasts. Cell Biochem Funct. 1990;8:57-64.
43. Bei L, Hu T, Qian ZM, Shen X. Extracellular Ca2+ regulates the respiratory burst of human neutrophils. Biochim Biophys Acta. 1998;1404:475-483.
44. Foyouzi-Youssefi R, Petersson F, Lew DP, Krause KH, Nusse O. Chemoattractant-induced respiratory burst: increases in cytosolic Ca2+ concentrations are essential and synergize with a kinetically distinct second signal. Biochem J. 1997;322:709-718.
45. Boulay F, Tardif M, Brouchen L, Vignais P. The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemislry. 1990;29:11,123-11,133.
46. Boulay F, Tardif M, Brouchen L, Vignais P. Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem Biophys Res Commun, 1990;168:1103-1109.
47. Murphy PM, Ozcelik T, Kenney RT, Tiffany HL, McDermott D, Francke U. A structural homologue of the N-formyl peptide receptor. Characterization and chromosome mapping of a peptide chemoattractant receptor family. J Biol Chem. 1992;267:7637-7643.
48. Ye RD, Cavanagh SL, Quehenberger O, Prossnitz ER, Cochrane CG. Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem Biophys Res Commun. 1992;30:582-589.
49. Fiore S, Serhan CN. Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction. Biochemistry. 1995;34:16,678-16,686.
50. Deng X, Ueda H, B SS, et al. A synthetic peptide derived from human immunodeficiency virus type 1 gp120 downregulates the expression and function of chemokine receptors CCR5 and CXCR4 in monocytes by activating the 7-transmembrane G-protein-coupled receptor FPRL1/LXA4R. Blood. 1999;94:1165-1173.
51. Su SB, Gong W, Gao JL, et al. A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J Exp Med. 1999;189:395-402.
52. Su SB, Gao JI, Gong WH, et al. T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41. attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors. J Immunol. 1999;162:5924-5930.
53. Diamond P, McGinty A, Sugrue D, Brady HR, Godson C. Regulation of leukocyte trafficking by lipoxins. Clin Chem Lab Med. 1999;37:293-297.
54. Serhan CN, Takano T, Gronert K, Chiang N, Clish CB. Lipoxin and aspirin-triggered 15-epi-lipoxin cellular interactions anti-inflammatory lipid mediators. Clin Chem Lab Med. 1999;37:299-309.
55. GewirtzAT, Fokin VV, Petasis NA, Serhan CN, Madara JL. LXA4, aspirin-triggered 15-epi-LXA4, and their analogs selectively downregulate PMN azurophilic degranulation. Am J Physiol. 1999;276:C988-994.
56. Maddox JF, Hachicha M, Takano T, Petasis NA, Fokin VV, Serhan CN. Lipoxin A4 stable analogs are potent mimetics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J Biol Chem. 1997;272:6972-6978.
57. Richardson RM, Ali H, Tomhave ED, Haribabu B, Snyderman R. Cross-desensitization of chemoattractant receptors occurs at multiple levels. Evidence for a role for inhibition of phospholipase C activity. J Biol Chem. 1995;270:27,829-27,833.
58. Tomhave ED, Richardson RM, Didsbury JR, Menard L, Snyderman R, Ali H. Cross-desensitization of receptors for peptide chemoattractants. Characterization of a new form of leukocyte regulation. J Immunol. 1994;153:3267-3275.
59. Richardson RM, DuBose RA, Ali H, Tomhave ED, Haribabu B, Snyderman R. Regulation of human interleukin-8 receptor A: identification of a phosphorylation site involved in modulating receptor functions. Biochemistry. 1995;34:14,193-14,201.
60. Richardson RM, Pridgen BC, Haribabu B, Ali H, Snyderman R. Differential cross-regulation of the human chemokine receptors CXCR1 and CXCR2. Evidence for time-dependent signal generation. J Biol Chem. 1998;273:23,830-23,836.
61. Schiffmann E, Corcoran BA, Wahl SM. N-formylmethionyl peptides as chemoattractants for leukocytes. Proc Natl Acad Sci USA. 1975;72:1059-1062.
62. Lamzin VS, Dauter Z, Wilson KS. How nature deals with stereoisomers. Curr Opin Struct Biol. 1995;5:830-836.
63. Imai K, Fukushima T, Santa T, et al. Analytical chemistry and biochemistry of D-amino acids. Biomed Chromatogr. 1996;10:303-312.
64. Fabbri E, Spisani S, Biondi C, et al. Two for-Met-Leu-Phe-OMe analogues trigger selective neutrophil responses. A differential effect on cytosolic free Ca2+. Biochim Biophys Acta. 1997;1359:233-240.
65. Gao JL, Becker EL, Freer RJ, Muthukumaraswamy N, Murphy PM. A high potency nonformylated peptide agonist for the phagocyte N-formylpeptide chemotactic receptor. J Exp Med. 1994;180:2191-2197.
66. Bellavite P, Carletto A, Biasi D, et al. Studies of skin-window exudate human neutrophils: complex patterns of adherence to serum-coated surfaces in dependence on FMLP doses. Inflammation. 1994;18:575-587.
67. Tellado JM, Christou NV. Circulating and exudative polymorphonuclear neutrophil priming and oxidative capacity in anergic surgical patients. Arch Surg. 1993;128:691-695.
68. Yee J, Giannias B, Kapadia B, Chartrand L, Christou NV. Exudative neutrophils. Modulation of microbicidal function in the inflammatory microenvironment. Arch Surg. 1994;129:99-105.
69. Karlsson A, Follin P, Leffler H, Dahlgren C. Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils. Blood. 1998;91:3430-3438.
70. Follin P, Wymann MP, Dewald B, Ceska M, Dahlgren C. Human neutrophil migration into skin chambers is associated with production of NAP-1/ILS and C5a. Eur J Haematol. 1991;47:71-76.
71. Kuhns DB, DeCarto E, Hawk DM, Gallin JI. Dynamics of the cellular and humoral components of the inflammatory response elicited in skin blisters in humans. J Clin Invest. 1992;89:1734-1740.
72. Hallett MB, Lloyds D. Neutrophil priming: the cellular signals that say 'amber' but not 'green'. Immunol Today. 1995;16:264-268.
73. Tauber AI, Karnad AB, Hartshorn KL, Myers JB, Schwartz JH. Parameters of Neutrophil Activation: Models of Priming and Deactivation: Biochemistry of the Acute Allergic Reactions: Fifth International Symposium. New York, NY: Alan R. Liss, Inc; 1989:297-309.
74. Sebaldt RJ, Prpic V, Hollenbach PW, Adams DO, Uhing RJ. IFN-gamma potentiates the accumulation of diacylglycerol in murine macrophages. J Immunol. 1990;145:684-689.
75. Sengeløv H, Follin P, Kjeldsen L, Lollike K, Dahlgren C, Borregaard N. Mobilization of granules and secretory vesicles during in vivo exudation of human neutrophils. J Immunol. 1995;154:4157-165.
76. Sengeløv H. Secretory vesicles of human neutrophils. Eur J Haematol Suppl. 1996;58:1-24.
77. Sengeløv H, Boulay F, Kjeldsen L, Borregaard N. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem J. 1994;299:473-479.